• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Gentherm Announces Dr. Ken Washington as New Independent Director

    10/2/23 8:00:00 AM ET
    $AMZN
    $F
    $MCK
    $MDT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Consumer Discretionary
    Get the next $AMZN alert in real time by email

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023.

    Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technology platforms across Medtronic's portfolio. Prior to joining Medtronic, Dr. Washington served as the Vice President of Software Engineering, Consumer Robotics for Amazon Lab126, a premier innovation hub and subsidiary of Amazon.com, Inc. (NASDAQ:AMZN). At Amazon Lab 126, Dr. Washington was responsible for all aspects of the profitability of Amazon's consumer robotics business unit. Before Amazon Lab 126, he held varying positions at Ford Motor Company (NYSE:F), including serving as Chief Technology Officer. At Ford, he led the worldwide research organization, oversaw the development and implementation of Ford's technology strategy and plans, oversaw the autonomous vehicle program, and played a key role in Ford's expansion into emerging mobility opportunities. Dr. Washington worked at Lockheed Martin Corporation as Vice President of the Advanced Technology Center and its first Chief Privacy Officer. Dr. Washington also served for approximately 21 years in various roles at Sandia National Laboratories, including as Chief Information Officer.

    Dr. Washington previously served as a member of the Board of Directors of McKesson Corporation (NYSE:MCK) from July 2019 to October 2021, including as a member of the Compliance and Finance Committees, as well as numerous private company boards and advisory boards of academic institutions.

    "We are pleased to welcome Ken to Gentherm's Board of Directors," said Ronald Hundzinski, Chair of the Board of Gentherm. "Ken brings years of experience in technology, research, and strategy across global automotive and medical organizations that will be a valuable asset to Gentherm's Board."

    "Ken's strong track record of leading technology development and execution makes him an ideal Board member to help drive innovation and strategy to strengthen shareholder value," said Phil Eyler, President and CEO of Gentherm. "I look forward to his insight and counsel and am excited for him to join as a new member of our Board of Directors."

    Dr. Washington earned his bachelor's, master's, and doctorate degrees in nuclear engineering from Texas A&M University.

    Investor Contact

    Yijing Brentano

    [email protected]

    248.308.1702

    Media Contact

    Melissa Fischer

    [email protected]

    248.289.9702

    About Gentherm

    Gentherm (NASDAQ:THRM) is the global market leader in innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests, and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.



    Primary Logo

    Get the next $AMZN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMZN
    $F
    $MCK
    $MDT

    CompanyDatePrice TargetRatingAnalyst
    Ford Motor Company
    $F
    4/30/2025Underperform → Peer Perform
    Wolfe Research
    Ford Motor Company
    $F
    4/23/2025$10.00Neutral
    Citigroup
    Amazon.com Inc.
    $AMZN
    4/23/2025$275.00 → $235.00Outperform
    Telsey Advisory Group
    Amazon.com Inc.
    $AMZN
    4/22/2025$250.00 → $240.00Buy
    Jefferies
    Amazon.com Inc.
    $AMZN
    4/21/2025$195.00Strong Buy → Outperform
    Raymond James
    Amazon.com Inc.
    $AMZN
    4/16/2025$270.00 → $230.00Overweight
    Cantor Fitzgerald
    Amazon.com Inc.
    $AMZN
    4/14/2025$273.00 → $225.00Buy
    Citigroup
    Amazon.com Inc.
    $AMZN
    4/14/2025$287.00 → $206.00Buy
    Deutsche Bank
    More analyst ratings

    $AMZN
    $F
    $MCK
    $MDT
    SEC Filings

    See more
    • SEC Form 8-K filed by Gentherm Inc

      8-K - Gentherm Inc (0000903129) (Filer)

      5/8/25 4:38:13 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MCKESSON CORP (0000927653) (Filer)

      5/8/25 4:06:16 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 13F-HR filed by Amazon.com Inc.

      13F-HR - AMAZON COM INC (0001018724) (Filer)

      5/6/25 4:45:24 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions

      McKesson Corporation (NYSE:MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 8th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inves

      5/8/25 4:10:00 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • Medtronic to announce financial results for its fourth quarter and full fiscal year 2025

      GALWAY, Ireland, May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2025, which ended on Friday, April 25, 2025. Medtronic will host a video webcast at 7:00 a.m. CDT on May 21, 2025, to discuss results for its fourth quarter and full fiscal year 2025. The webcast can be a

      5/7/25 6:07:00 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

      Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign GALWAY, Ireland, May 7, 2025 /PRNewswire/ -- A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-figures. Despite cardiovascular disease being the #1 killer of women in the U.S., many women are still unaware of the risk and the importance of heart health. The survey, endorsed by WomenHeart and conducted by Wakefield Research, found that nearly half of women (45%) were mor

      5/7/25 10:02:00 AM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Financials

    Live finance-specific insights

    See more
    • McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions

      McKesson Corporation (NYSE:MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 8th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inves

      5/8/25 4:10:00 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • Ford Reports First Quarter 2025 Financial Results

      Ford Motor Company (NYSE:F) today reported first quarter 2025 financial results. Visit the company's Investor Relations website at shareholder.ford.com to view the earnings release, earnings presentation and other supporting material. At 5:00 p.m. ET, Ford and Ford Motor Credit Company management will hold a conference call to discuss these financial results. For the webcast, click here. Representatives of the investment community will be able to ask questions on the call. The webcast will be available for replay for approximately one week following the call at this link. About Ford Motor Company Ford Motor Company (NYSE:F) is a global company based in Dearborn, Michigan, committed to h

      5/5/25 4:05:00 PM ET
      $F
      Auto Manufacturing
      Consumer Discretionary
    • Amazon.com Announces First Quarter Results

      Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its first quarter ended March 31, 2025. Net sales increased 9% to $155.7 billion in the first quarter, compared with $143.3 billion in first quarter 2024. Excluding the $1.4 billion unfavorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 10% compared with first quarter 2024. North America segment sales increased 8% year-over-year to $92.9 billion. International segment sales increased 5% year-over-year to $33.5 billion, or increased 8% excluding changes in foreign exchange rates. AWS segment sales increased 17% year-over-year to $29.3 billion. Operati

      5/1/25 4:01:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

      SC 13G/A - AMAZON COM INC (0001018724) (Subject)

      11/8/24 4:33:15 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

      SC 13G/A - AMAZON COM INC (0001018724) (Filed by)

      11/7/24 5:23:12 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

      SC 13G/A - Medtronic plc (0001613103) (Subject)

      2/13/24 5:09:43 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Ford Motor upgraded by Wolfe Research

      Wolfe Research upgraded Ford Motor from Underperform to Peer Perform

      4/30/25 7:24:30 AM ET
      $F
      Auto Manufacturing
      Consumer Discretionary
    • Citigroup initiated coverage on Ford Motor with a new price target

      Citigroup initiated coverage of Ford Motor with a rating of Neutral and set a new price target of $10.00

      4/23/25 9:15:28 AM ET
      $F
      Auto Manufacturing
      Consumer Discretionary
    • Telsey Advisory Group reiterated coverage on Amazon with a new price target

      Telsey Advisory Group reiterated coverage of Amazon with a rating of Outperform and set a new price target of $235.00 from $275.00 previously

      4/23/25 6:39:39 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • March 11, 2025 - FDA Roundup: March 11, 2025

      For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

      3/13/25 3:14:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • November 14, 2023 - FDA Roundup: November 14, 2023

      For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

      11/14/23 3:26:18 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, General Manager, Europe Stocker Thomas bought $8,011 worth of shares (321 units at $24.96), increasing direct ownership by 2% to 20,638 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      4/29/25 8:46:29 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • President & CEO Presley William T. bought $74,010 worth of shares (3,000 units at $24.67), increasing direct ownership by 2% to 161,103 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      4/28/25 4:15:52 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • Thornton John L bought $299,463 worth of shares (24,790 units at $12.08), increasing direct ownership by 7% to 389,576 units (SEC Form 4)

      4 - FORD MOTOR CO (0000037996) (Issuer)

      6/7/24 4:20:19 PM ET
      $F
      Auto Manufacturing
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Washington Kenneth E was granted 5,075 shares, increasing direct ownership by 121% to 9,265 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      5/9/25 5:04:20 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • Director Stacey John was granted 5,075 shares, increasing direct ownership by 29% to 22,820 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      5/9/25 4:59:53 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • Director Meter Elizabeth was granted 5,075 shares, increasing direct ownership by 49% to 15,372 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      5/9/25 4:54:35 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Leadership Updates

    Live Leadership Updates

    See more
    • Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

      NEW HOPE, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2024 financial results and provided a fourth quarter business update. "We remain highly focused on execution of the BACKBEAT global pivotal study, which we believe has the potential to deliver landmark results that can establish AVIM therapy as a new standard of care for the treatment of uncontrolled hypertension in patients already indicated for a pacemaker. We also believe it can lay the foundation for

      3/31/25 4:21:30 PM ET
      $MDT
      $OBIO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
      Medicinal Chemicals and Botanical Products
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance
    • Sleep Number Board Names Linda Findley as President and Chief Executive Officer

      Findley has a demonstrated record of accelerating growth and transformation across diverse consumer business models Phillip Eyler to become independent Board Chair, effective after the 2025 Annual Meeting of Shareholders Sleep Number Corporation (NASDAQ:SNBR) today announced that its Board of Directors (the "Board") has appointed Linda Findley as the company's new President and Chief Executive Officer, and as a member of the Board, effective April 7, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305807579/en/Linda Findley will assume the role of Sleep Number President and CEO on April 7, 2025 (Photo: Business Wire) Fi

      3/5/25 4:15:00 PM ET
      $APRN
      $ETSY
      $RL
      $SNBR
      Catalog/Specialty Distribution
      Consumer Discretionary
      Business Services
      Apparel